16
Views
1
CrossRef citations to date
0
Altmetric
ANATOMICAL PATHOLOGY

Active caspase 3 and DNA fragmentation as markers for apoptotic cell death in primary and metastatic liver tumours

, , , , , & show all
Pages 558-564 | Received 21 Dec 2006, Accepted 26 Mar 2007, Published online: 06 Jul 2009
 

Abstract

Aims: The induction of tumour cell death by apoptosis is a major goal of cancer therapy and the in situ detection of apoptosis in tumour tissue has become an important diagnostic parameter. Different apoptosis detection methods assess distinct biochemical processes in the dying cell. Thus, their direct comparison is mandatory to evaluate their diagnostic value. The aim of this study was to compare the immunohistochemical detection of active caspase 3 and single‐stranded DNA in primary and metastatic liver tumours as markers of apoptotic cell death.

Methods: We studied detection of active caspase 3 and single‐stranded DNA in 20 primary hepatocellular carcinomas (HCC) and 20 liver metastases from colorectal carcinomas (CRC) using immunohistochemistry on paraffin sections.

Results: Our results reveal that both methods are suitable and sensitive techniques for the in situ detection of apoptosis, however, they also demonstrate that immunohistochemistry for active caspase 3 and single‐stranded DNA have differential sensitivities in HCC and CRC.

Conclusion: The sensitivity of apoptosis detection using immunohistochemistry for active caspase 3 and single‐stranded DNA may be tumour cell type dependent.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.